Lukas Sveikata, MD

Vascular & Cognitive Neurology | VCID & CAA 🧠🩸 @unige_en @NeuroGeneva | @MGHNeurology @harvardmed

[Lukas Sveikata, MD @lsveikata]

Check out our new piece on #CAA #AD interplay and implications for #amyloid clearing and #aducanumab, published today @StrokeAHA_ASA. Screening for CAA might be 🔑 to reduce ARIA risk. Thankful🙏 to my mentors Dr Viswanathan @a_charidimou @SMGreenbergNeur https://t.co/y7fB5WQbMM

[Lukas Sveikata, MD @lsveikata]

We also observed an association between higher BPV and cognitive decline over a 2-year period, supporting BPV as a potential novel risk factor for cognitive deterioration.

[Lukas Sveikata, MD @lsveikata]

💡 Glad to share our latest paper published in #JAHA on long-term blood pressure fluctuations and their association with cerebral amyloid angiopathy (CAA)-related ischemic brain lesions. 🧠💥

[Lukas Sveikata, MD @lsveikata]

Our findings suggest that pts w/ CAA may be vulnerable to increased long-term BPV, potentially driven by underlying small vessel degeneration.

[World Stroke Academy @WorldStrokeEd]

#MondayTip
#TRIDENT

💊One pill could change post-ICH care.

🧠Low-dose triple antihypertensive therapy ↓ recurrent stroke by 39% and improved BP control vs standard care

☝️Simpler regimens may beat therapeutic inertia

🔗https://t.co/LUy8wIZ6dD

[iCAA @iCAAassociation]

🚨🧠 happening now: exciting session on CAA on the intersection between stroke, neurodegeneration x neuroinflammation covering a large spectrum of CAA from ICH to degeneration, neuroinflammation, iatrogenic forms and back! Thought provoking session. #ESOC2026

[Stroke AHA/ASA @StrokeAHA_ASA]

Faster Thrombolysis, Sharper Minds: Early Alteplase or Tenecteplase Linked to Better Poststroke Cognition

In this #BloggingStroke post, Anel Karisik discusses #Stroke article by Sujanthan et al. https://t.co/VRnsNUJy6L

[SFCNS and YouCliN @SFCNSyouclin]

Last chance to apply until June 30 to YouCliN Research, Thesis, And Education Awards !

Link👇

[World Stroke Academy @WorldStrokeEd]

#MondayTip
📊Pooled INTERACT data

✅Intensive BP lowering improves recovery in ICH
⏱️When started <3h (cutoff: 2.6h)➡️reduces haematoma growth
☝️Greatest benefit in mild–moderate ICH (ICH score)
🚨Early treatment improves outcomes👉supports CODE-ICH systems & future trial design

[David Seiffge @DavidSeiffge]

News from the Swiss Stroke Registry by ⁦@mbgoeldlin: DWI-lesions in ICH are frequent, already on admission before any intervention; associationbwith CAA and SVD burden. Suitable surrogate outcome in trials?@StrokeBern⁩ ⁦@GreenJournal⁩ https://t.co/ULyCCzu7O8

[SFCNS and YouCliN @SFCNSyouclin]

Still time to apply for YouCliN awards before June 30 !

[SFCNS and YouCliN @SFCNSyouclin]

We invite you to apply for the one-month YouCliN NeXus Clinical Fellowship Award, a great opportunity for early-career clinician-scientists in Switzerland to enhance their clinical neuroscience expertise. Apply now!

🔗https://t.co/07F6B9lUjZ

[International Journal of Stroke @IntJStroke]

🧠🩸White matter hyperintensities are independently associated with systemic vascular aging and cerebrovascular dysfunction

https://t.co/d0xKiWYJsw @alastair_webb

[Dearbhla Kelly @DearbhlaKelly4]

We explore the kidney-immune-brain axis in this latest paper, focusing on mechanisms of inflammation in CKD, its impact on stroke pathogenesis, prognosis & the potential role of anti-inflammatory agents https://t.co/Qae6iIyiDi @StrokeAHA_ASA @EoinKr @NDCNOxford @QueensCollegeOx

[Lukas Sveikata, MD @lsveikata]

🌟Update on basilar artery occlusion stroke by Prof Patrik Michel (CHUV).

💡Revascularisation is crucial for BAO like a parachute jumping from a plane BUT it’s subject to the height/severity of the fall/stroke!

💫Swiss Stroke Society meeting @inselgruppe

[Stroke AHA/ASA @StrokeAHA_ASA]

#STROKE: This narrative review by Mai et al. critically appraises the literature on recovery trajectories after intracranial hemorrhage as compared with acute ischemic stroke. #AHAJournals https://t.co/YDBinxLvSG @ArKatsanos @Ash_Shoamanesh

[Stroke AHA/ASA @StrokeAHA_ASA]

#STROKE: Longitudinal changes in CBF and cerebrovascular resistance index may have bidirectional relationship with development of subclinical vascular brain disease in older adults. #AHAJournals https://t.co/GaAD6DPzK7 @YuanMaHSPH @fjwltrs @WiroNiessen @HarvardEpi @univgroningen

[Lukas Sveikata, MD @lsveikata]

@Laura_Sofia_S @_michael_scholl @EllenSingletonn Congratulations Laura ! Very exciting news ! 👏

[SFCNS and YouCliN @SFCNSyouclin]

Exciting discussions underway at the #YouCliN Retreat in Thun! 🌟 Key topics on the agenda: fostering interdisciplinarity in clinical neurosciences, advancing the Common Trunk program, and championing Brain Health. 🧠 Stay tuned for insights and updates!